<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005892</article-id><article-id pub-id-type="pmc">PMC11861582</article-id><article-id pub-id-type="doi">10.3390/vetsci12020132</article-id><article-id pub-id-type="publisher-id">vetsci-12-00132</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Difference Analysis on Virulence Genes, Biofilms and Antimicrobial Susceptibility of <italic toggle="yes">Escherichia coli</italic> from Clinical and Subclinical Bovine Mastitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zuo</surname><given-names>Jiakun</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-vetsci-12-00132" ref-type="aff">1</xref><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Lv</surname><given-names>Zhaoyang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref><xref rid="af3-vetsci-12-00132" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Lian</surname><given-names>Liyan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Zihao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af3-vetsci-12-00132" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Shaodong</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af1-vetsci-12-00132" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Haiyang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jing</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af3-vetsci-12-00132" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Zihao</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af1-vetsci-12-00132" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Yong</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af1-vetsci-12-00132" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Wei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af3-vetsci-12-00132" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Wei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Huifang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af4-vetsci-12-00132" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2079-9361</contrib-id><name><surname>Chen</surname><given-names>Zhaoguo</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5233-8770</contrib-id><name><surname>Yi</surname><given-names>Yunpeng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af5-vetsci-12-00132" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Xiangan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af2-vetsci-12-00132" ref-type="aff">2</xref><xref rid="c1-vetsci-12-00132" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Jinfeng</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-vetsci-12-00132" ref-type="aff">1</xref><xref rid="c1-vetsci-12-00132" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Dos Santos</surname><given-names>Marcos Veiga</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-12-00132"><label>1</label>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China</aff><aff id="af2-vetsci-12-00132"><label>2</label>Shanghai Veterinary Research Institute, The Chinese Academy of Agricultural Sciences (CAAS), 518 Ziyue Road, Shanghai 200241, China</aff><aff id="af3-vetsci-12-00132"><label>3</label>College of Animal Science and Technology, Tarim University, Alar 843300, China</aff><aff id="af4-vetsci-12-00132"><label>4</label>Engineering Research Center for the Prevention and Control of Animal Original Zoonosis, Fujian Province, College of Life Science, Longyan University, Longyan 364012, China</aff><aff id="af5-vetsci-12-00132"><label>5</label>Shandong Provincial Animal and Poultry Green Health Products Creation Engineering Laboratory, Institute of Poultry Science, Shandong Academy of Agricultural Science, Jinan 250100, China</aff><author-notes><corresp id="c1-vetsci-12-00132"><label>*</label>Correspondence: <email>hanxgan@shvri.ac.cn</email> (X.H.); <email>miaojinfeng@njau.edu.cn</email> (J.M.); Tel.: +86-21-54225517 (X.H.); +25-84395950 (J.M.)</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>132</elocation-id><history><date date-type="received"><day>26</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>26</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Bovine mastitis is the most common disease in the dairy industry worldwide and results in serious damage to both animal welfare and economic benefit. <italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E. coli</italic>) is one of the important pathogens that could induce clinical and subclinical mastitis in dairy cows. Bovine mastitis-related <italic toggle="yes">E. coli</italic> show considerable genetic diversity, and the differences between the clinical and subclinical mastitis-related strains are unclear. This study compared the two groups of strains from the aspects of molecular subtyping, virulence genes, biofilms and resistance. This study aimed to investigate the molecular epidemiological characteristics of mastitis-related <italic toggle="yes">E. coli</italic> and to provide references for their prevention.</p></abstract><abstract><title>Abstract</title><p><italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E. coli</italic>) has the ability to induce clinical and subclinical mastitis in dairy cows, causing a huge loss for the dairy industry. In this study, 51 subclinical mastitis isolates and 36 clinical mastitis isolates from eight provinces of China between 2019 and 2021 were used to investigate the differences in their biological characteristics. The results showed that B1 (52.9%) and A (39.1%) were the predominant phylogroups; R1 (50.6%) was the predominant lipopolysaccharide (LPS) core type; and 44 STs (ST10 and ST58 were the most sequence-prevalent STs) and 2 new STs (ST14828 and ST14829) were identified; however, no significant difference was observed between the clinical and subclinical group strains. To compare the virulence gene differences between the clinical and subclinical mastitis-related isolates, 18 common virulence genes (including <italic toggle="yes">afaE</italic>, <italic toggle="yes">eaeA</italic>, <italic toggle="yes">papC</italic>, <italic toggle="yes">saa</italic>, <italic toggle="yes">sfa</italic>, <italic toggle="yes">ompA</italic>, <italic toggle="yes">aer</italic>, <italic toggle="yes">irp2</italic>, <italic toggle="yes">iucD</italic>, <italic toggle="yes">escV</italic>, <italic toggle="yes">sepD</italic>, <italic toggle="yes">east1</italic>, <italic toggle="yes">estB</italic>, <italic toggle="yes">stx2e</italic>, <italic toggle="yes">CNF1</italic>, <italic toggle="yes">cba</italic>, <italic toggle="yes">hlyA</italic> and <italic toggle="yes">traT</italic>) were determined using the PCR method. The results showed that the detection rates of <italic toggle="yes">traT</italic>, <italic toggle="yes">irp2</italic> and <italic toggle="yes">iucD</italic> in clinical mastitis isolates were significantly higher than those in subclinical mastitis isolates (<italic toggle="yes">p</italic> &#x002c2; 0.05). Meanwhile, subclinical-group <italic toggle="yes">E. coli</italic> had stronger biofilm formation abilities than the clinical group (<italic toggle="yes">p</italic> &#x0003c; 0.05) in 78 (89.7%) mastitis-related <italic toggle="yes">E. coli</italic> that could form biofilms. Furthermore, 87 mastitis-related <italic toggle="yes">E. coli</italic> showed severe resistance against tetracycline (37.9%), ampicillin (36.8%), streptomycin (34.5%) and cotrimoxazole (28.7%); their most prevalent resistance genes were <italic toggle="yes">blaCTX-M</italic> (33.3%), <italic toggle="yes">tetA</italic> (27.6%), <italic toggle="yes">sul2</italic> (18.4%) and <italic toggle="yes">strB</italic> (28.7%). It was noteworthy that the clinical-group strains had a higher resistance against ampicillin and possessed higher amounts of the resistance gene <italic toggle="yes">blaCTX-M</italic> (<italic toggle="yes">p</italic> &#x0003c; 0.05) compared to the subclinical group. This study aims to provide references for preventing the <italic toggle="yes">E. coli</italic> isolates from inducing different types of mastitis.</p></abstract><kwd-group><kwd><italic toggle="yes">Escherichia coli</italic></kwd><kwd>bovine mastitis</kwd><kwd>MLST</kwd><kwd>biofilm</kwd><kwd>virulence gene</kwd><kwd>antimicrobial resistance</kwd></kwd-group><funding-group><award-group><funding-source>Shanghai Agriculture Applied Technology Development Program</funding-source><award-id>T2023106</award-id></award-group><award-group><funding-source>Jiangsu Province Key Research and Development Program</funding-source><award-id>BE2022384</award-id></award-group><award-group><funding-source>Natural Science Foundation of Fujian Province of China</funding-source><award-id>2021J01132429</award-id></award-group><funding-statement>This work was supported by Shanghai Agriculture Applied Technology Development Program (Grant No. T2023106), the Jiangsu Province Key Research and Development Program (Grant No. BE2022384) and the Natural Science Foundation of Fujian Province of China (Grant No. 2021J01132429).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-12-00132"><title>1. Introduction</title><p>Bovine mastitis is considered to be a devastating disease for the dairy industry throughout the world. It is responsible for great losses for dairy producers and the milk processing industry as a result of reduced milk production, the alteration of milk composition, treatment costs and even severe systemic infection [<xref rid="B1-vetsci-12-00132" ref-type="bibr">1</xref>]. Many factors contribute to the development of mastitis, including hosts, pathogens and environmental factors; bacterial infection is the most crucial one [<xref rid="B2-vetsci-12-00132" ref-type="bibr">2</xref>]. Most bovine mastitis pathogens are classified as contagious and environmental pathogens depending on their distribution in their natural habitat and on their mode of transmission from their natural habitat to the mammary glands of cows [<xref rid="B3-vetsci-12-00132" ref-type="bibr">3</xref>]. Among the contagious pathogens, <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Streptococcus dysgalactiae</italic> and <italic toggle="yes">Streptococcus agalactiae</italic> are predominant, while <italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E. coli</italic>), <italic toggle="yes">Klebsiella pneumoniae</italic>, coagulase-negative staphylococci (CNS) and <italic toggle="yes">Streptococcus uberis</italic> are the most common environmental pathogens [<xref rid="B4-vetsci-12-00132" ref-type="bibr">4</xref>,<xref rid="B5-vetsci-12-00132" ref-type="bibr">5</xref>]. Compared with contagious pathogens, environmental pathogens are more difficult to control because they exist in the environment of dairy cows and can transmit to the mammary glands at any time during the cows&#x02019; daily activities, such as lying down or milking.</p><p>According to the clinical symptoms, mastitis can be also classified into clinical and subclinical forms. Clinical mastitis can be identified easily based on visible symptoms of the udders, such as redness, warmth, swelling, pain, fever and abnormal lactation; no visible symptoms are observed in cows with subclinical mastitis [<xref rid="B6-vetsci-12-00132" ref-type="bibr">6</xref>]. Although the level of inflammation of clinical mastitis is more serious than that of subclinical mastitis, the economic loss induced by subclinical mastitis cannot be overlooked due to its higher prevalence, longer duration and the damage it causes in relation to milk quality and production [<xref rid="B4-vetsci-12-00132" ref-type="bibr">4</xref>].</p><p>Due to its high frequency, serious resistance and huge economic loss, mastitis caused by <italic toggle="yes">E. coli</italic> is a global concern in the dairy farming industry. Mastitis caused by <italic toggle="yes">E. coli</italic> occurs at a high frequency in dairy farming, and almost 80% of mastitis found in mammary infections during the dry period is caused by <italic toggle="yes">E. coli</italic> [<xref rid="B7-vetsci-12-00132" ref-type="bibr">7</xref>]. <italic toggle="yes">E. coli</italic> is often related to rapid-onset, acute mastitis with severe symptoms, and it is also observed in subclinical mastitis [<xref rid="B8-vetsci-12-00132" ref-type="bibr">8</xref>]. In the past, most studies focused on clinical mastitis-related <italic toggle="yes">E. coli</italic>, and the differences between the clinical and subclinical strains were unclear [<xref rid="B1-vetsci-12-00132" ref-type="bibr">1</xref>].</p><p>Antibiotics are still the most common method of treatment for coliform mastitis. However, due to their extensive use, the emergence of antimicrobial-resistant bacteria has posed a challenge to both the prevention of bovine mastitis and public health throughout the food chain. Antibiotic-resistant <italic toggle="yes">E. coli</italic> in milk is a serious concern since this bacterial species has a great capacity to accumulate and transmit antibiotic resistance genes (ARGs) through horizontal gene transfer [<xref rid="B9-vetsci-12-00132" ref-type="bibr">9</xref>].</p><p>To learn more about the features of mastitis-related <italic toggle="yes">E. coli</italic> strains, in this study, 87 <italic toggle="yes">E. coli</italic> isolated from 51 samples of subclinical mastitis milk and 36 samples of clinical mastitis milk, respectively, in China between 2019 and 2021, were used as the main study objects, and their biological characteristics were determined. This study aims to provide references for studying the prevention of mastitis-related <italic toggle="yes">E. coli.</italic></p></sec><sec id="sec2-vetsci-12-00132"><title>2. Materials and Methods</title><sec id="sec2dot1-vetsci-12-00132"><title>2.1. Bovine Mastitis-Related E. coli</title><p>In this study, 87 <italic toggle="yes">E. coli</italic> strains were isolated from the milk samples of different dairy cows in China between 2019 and 2021, including 51 subclinical mastitis-related strains and 36 clinical mastitis-related strains. The diagnosis of clinical and subclinical bovine mastitis cases, as well as the milk collection, was performed as described previously [<xref rid="B10-vetsci-12-00132" ref-type="bibr">10</xref>]. Cows suffering with clinical mastitis were diagnosed based on clinical signs, e.g., the swelling of the udder, tenderness to touch, fever and depression (<xref rid="vetsci-12-00132-f001" ref-type="fig">Figure 1</xref>a). Subclinical bovine mastitis cases were diagnosed using the California Mastitis Test (CTM) method and were tested using the diagnostic reagent Lanzhou Mastitis Test (LMT) (<xref rid="vetsci-12-00132-f001" ref-type="fig">Figure 1</xref>b&#x02013;d). The <italic toggle="yes">E. coli</italic> strains were isolated using MacConkey agar. The milk samples were cultivated onto MacConkey agar using sterile cotton swabs and were then incubated at 37 &#x000b0;C overnight. The lactose-positive colonies were picked into Luria&#x02013;Bertani (LB) medium and were identified via the PCR amplification of the <italic toggle="yes">phoA</italic> gene with the primers phoA-F/phoA-R as well as 16S rRNA gene sequencing. All the primers used in this study are listed in <xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Table S1</xref>, and detailed information on the isolates is listed in <xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Table S2</xref>.</p></sec><sec id="sec2dot2-vetsci-12-00132"><title>2.2. Extraction of Bacterial Genomic DNA</title><p>The <italic toggle="yes">E. coli</italic> strains isolated from cows with mastitis were streaked on LB agar plates and cultured at 37 &#x000b0;C overnight. A single colony of each strain was inoculated into 5 mL LB broth. The genomic DNA of the bacteria was extracted from a 1 mL overnight culture using a boiling-water extraction method, as detailed in a previous study [<xref rid="B11-vetsci-12-00132" ref-type="bibr">11</xref>].</p></sec><sec id="sec2dot3-vetsci-12-00132"><title>2.3. Phylogenetic Analysis, Lipopolysaccharide (LPS) Core Types and Multilocus Sequence Typing (MLST) of Mastitis-Related E. coli</title><p>To analyze the strains and then verify whether there are any connections with, e.g., animals or case etiology, clinical <italic toggle="yes">E. coli</italic> isolates were phylotyped according to Clermont&#x02019;s quadruplex PCR methods [<xref rid="B12-vetsci-12-00132" ref-type="bibr">12</xref>]. The genomic DNA of the <italic toggle="yes">E. coli</italic> isolates served as templates for the PCR reactions. The <italic toggle="yes">E. coli</italic> isolates were assigned to one of the eight phylogroups (A, B1, B2, C, D, E, F and clade I) by scoring the presence/absence of the genes in the order <italic toggle="yes">arpA</italic>/<italic toggle="yes">chuA</italic>/<italic toggle="yes">yjaA</italic>/<italic toggle="yes">TspE4.C2</italic> using a quadruplex PCR assay. All the primers used in this study are listed in <xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Table S1</xref>.</p><p>The LPS core types of the <italic toggle="yes">E. coli</italic> isolates were determined via the PCR amplification of specific genes of the R1, R2, R3, R4 and K12 oligosaccharides. The primer sequences and PCR reaction were performed as in a previous study [<xref rid="B13-vetsci-12-00132" ref-type="bibr">13</xref>].</p><p>The MLST of the isolates was performed using the standardized Achtman scheme by sequencing seven housekeeping genes (<italic toggle="yes">adk</italic>, <italic toggle="yes">fumC</italic>, <italic toggle="yes">gyrB</italic>, <italic toggle="yes">icd</italic>, <italic toggle="yes">mdh</italic>, <italic toggle="yes">purA</italic> and <italic toggle="yes">recA</italic>), as has been previously described [<xref rid="B14-vetsci-12-00132" ref-type="bibr">14</xref>]. Alleles and sequence type (ST) were assigned according to the MLST database (<uri xlink:href="https://pubmlst.org">https://pubmlst.org</uri>, accessed on 11 November 2022). The whole genomes of strains with novel STs were obtained using next-generation sequencing (NGS) and were submitted to the enterobase website (<uri xlink:href="https://enterobase.warwick.ac.uk/">https://enterobase.warwick.ac.uk/</uri>, accessed on 11 July 2023) for molecular typing. A phylogenetic tree was created according to the STs using the goeBURST algorithm from PHYLOViZ Online (<uri xlink:href="https://online.phyloviz.net">https://online.phyloviz.net</uri>, accessed on 24 July 2023).</p></sec><sec id="sec2dot4-vetsci-12-00132"><title>2.4. Distribution of Virulence Genes in Mastitis-Related E. coli</title><p>To analyze the distribution of virulence genes in mastitis-related <italic toggle="yes">E. coli</italic>, specific PCR primers (<xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Table S1</xref>) of genes related to adherence (<italic toggle="yes">afaE</italic>, <italic toggle="yes">eaeA</italic>, <italic toggle="yes">papC</italic>, <italic toggle="yes">saa</italic> and <italic toggle="yes">sfa</italic>), invasion factor (<italic toggle="yes">ompA</italic>), siderophores (<italic toggle="yes">aer</italic>, <italic toggle="yes">irp2</italic> and <italic toggle="yes">iucD</italic>), type III secretion system (T3SS) (<italic toggle="yes">escV</italic> and <italic toggle="yes">sepD</italic>) and toxins (<italic toggle="yes">east1</italic>, <italic toggle="yes">estB</italic>, <italic toggle="yes">stx2e</italic>, <italic toggle="yes">CNF1</italic>, <italic toggle="yes">cba</italic> and <italic toggle="yes">hlyA</italic>) and the serum resistance factor (<italic toggle="yes">traT</italic>) were synthesized by Sangon Biotech (China); they were used to amplify the common virulence genes in mastitis-derived <italic toggle="yes">E.coli</italic>. PCR reactions were performed according to the previously described methods.</p></sec><sec id="sec2dot5-vetsci-12-00132"><title>2.5. Biofilm Formation</title><p>The bacterial biofilms of the <italic toggle="yes">E. coli</italic> isolates were measured in 96-well polyvinyl chloride (PVC) microplates using the crystal violet method as described previously with some modification [<xref rid="B15-vetsci-12-00132" ref-type="bibr">15</xref>]. Briefly, bacteria that were cultured to <italic toggle="yes">OD</italic><sub>600</sub> = 1.0 were diluted 1:10 in LB, and 200 &#x003bc;L of the dilution was inoculated into 96-well microplates and cultured at 25 &#x000b0;C for 24 h. Each strain was repeated for 6 wells. The culture of the wells was washed thrice with PBS and dried off at 60 &#x000b0;C for 30 min. The wells were stained using 200 &#x003bc;L of 0.1% crystal violet for 15 min at 37 &#x000b0;C, and the excess crystal violet was washed off with PBS. After being air-dried, 200 &#x003bc;L of 95 % ethanol was added to the wells to dissolve the crystal violet; the absorbance at 595 nm (<italic toggle="yes">OD</italic><sub>595</sub>) was measured using a Synergy 2 microplate reader (BioTek, Winooski, VT, USA). Six wells with sterile LB were used as blank control.</p><p>The biofilm formation abilities of the strains were analyzed by the optical density of the sample (<italic toggle="yes">OD</italic><sub>sample</sub>, <italic toggle="yes">OD</italic><sub>s</sub>) differentiated by the critical OD (<italic toggle="yes">OD</italic><sub>control</sub>, <italic toggle="yes">OD</italic><sub>c</sub>). The <italic toggle="yes">OD</italic><sub>c</sub> value and objective criteria were calculated according to the methods of a previous study [<xref rid="B16-vetsci-12-00132" ref-type="bibr">16</xref>]. The <italic toggle="yes">OD</italic><sub>c</sub> value was calculated from the arithmetic mean of the absorbance of negative control wells with three times the SD. When <italic toggle="yes">OD</italic><sub>s</sub> &#x02264; <italic toggle="yes">OD</italic><sub>c</sub>, the bacteria did not form biofilms; when <italic toggle="yes">OD</italic><sub>c</sub> &#x0003c; <italic toggle="yes">OD</italic><sub>s</sub> &#x02264; 2<italic toggle="yes">OD</italic><sub>c</sub>, the bacteria had a weak ability to form biofilms; when 2<italic toggle="yes">OD</italic><sub>c</sub> &#x0003c; <italic toggle="yes">OD</italic><sub>s</sub> &#x02264; 4<italic toggle="yes">OD</italic><sub>c</sub>, the bacteria had a moderate ability to form biofilms; and when <italic toggle="yes">OD</italic><sub>s</sub> &#x0003e; 4<italic toggle="yes">OD</italic><sub>c</sub>, the bacterial ability to form biofilms was strong.</p></sec><sec id="sec2dot6-vetsci-12-00132"><title>2.6. Antimicrobial Susceptibility</title><p>The antimicrobial susceptibility of mastitis-related <italic toggle="yes">E. coli</italic> to 12 antimicrobial agents was measured by the Kirby&#x02013;Bauer disk diffusion method according to the Clinical and Laboratory Standards Institute guidelines [<xref rid="B17-vetsci-12-00132" ref-type="bibr">17</xref>]. In brief, bacteria with 0.5 MacFarland turbidities were coated on Mueller&#x02013;Hinton agar; then, commercially available disks were attached to the surface of the agar. After being incubated at 37 &#x000b0;C for 16 h, the diameter of the bacteriostatic zone was measured to assess the drug susceptibility of the bacteria. The commercial disks used here included <italic toggle="yes">&#x003b2;</italic>-lactam antimicrobials (ampicillin, cefradine, ceftazidime, cefepime and amoxicillin/clavulanate potassium), aminoglycoside antimicrobials (kanamycin, spectinomycin, gentamicin and streptomycin), tetracycline antimicrobials (tetracycline), phenicol antimicrobials (chloramphenicol), sulfonamide antimicrobials (cotrimoxazole), quinolone antimicrobials (ciprofloxacin and enrofloxacin) and polypeptide antimicrobials (polymyxin B), which were purchased from Wenzhou Kangtai Biotech (Taizhou, China). The drug breakpoints were referenced to criteria published by the CLSI (2020).</p></sec><sec id="sec2dot7-vetsci-12-00132"><title>2.7. Distribution of Common Antibiotic-Resistant Genes</title><p>Based on resistance gene data from the Antibiotic Resistance Genes Database (ARDB), specific primers for common tetracyline-resistance-related genes (<italic toggle="yes">tetA</italic>, <italic toggle="yes">tetB</italic> and <italic toggle="yes">tetC</italic>), <italic toggle="yes">&#x003b2;</italic>-lactamase genes (<italic toggle="yes">blaCTX-M</italic>, <italic toggle="yes">blaSHV</italic>, <italic toggle="yes">blaTEM</italic>, <italic toggle="yes">blaOXA</italic> and <italic toggle="yes">blaKPC</italic>), sulfonamide resistance genes (<italic toggle="yes">sul1</italic>, <italic toggle="yes">sul2</italic> and <italic toggle="yes">sul3</italic>) and aminoglycoside resistance genes (<italic toggle="yes">aadA</italic>, <italic toggle="yes">strA</italic> and <italic toggle="yes">strB</italic>) were used in this study; these are listed in <xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Table S2</xref>. The PCR reaction conditions were set as follows: 12.5 &#x003bc;L 2 &#x000d7; Es Taq MasterMix buffer (Cwbiotech, Taizhou, China), 1 &#x003bc;L of each primer (10 &#x003bc;M), 1 &#x003bc;L bacterial DNA and ddH<sub>2</sub>O up to the reaction volume. PCR amplification was carried out as follows: 4 min initial denaturation at 94 &#x000b0;C, 30 cycles of 40 s denaturation at 94 &#x000b0;C, 40 s annealing at primer-specific annealing temperature and 1 min extension at 72 &#x000b0;C followed by a 10 min final extension at 72 &#x000b0;C. The PCR products were identified using 1% agarose gel electrophoresis.</p><p>The subtypes of CTX-M were identified via the Sanger sequencing of the PCR production of CTX-M genes by Sangon Biotech (Shanghai, China). Then, the sequences were placed in the NCBI nucleotide database (<uri xlink:href="https://blast.ncbi.nlm.nih.gov">https://blast.ncbi.nlm.nih.gov</uri>, accessed on 14 June 2024) to distinguish the subtypes.</p></sec><sec id="sec2dot8-vetsci-12-00132"><title>2.8. Phylogenetic Analysis Tree</title><p>A phylogenetic tree of the 87 strains according to the seven housekeeping genes (<italic toggle="yes">adk</italic>, <italic toggle="yes">fumC</italic>, <italic toggle="yes">gyrB</italic>, <italic toggle="yes">icd</italic>, <italic toggle="yes">mdh</italic>, <italic toggle="yes">purA</italic> and <italic toggle="yes">recA</italic>) was created using neighbor-joining from the MEGA 11 software. The visualization, annotation and decoration of the trees were carried out utilizing tvBOT (<uri xlink:href="https://www.chiplot.online/tvbot.html">https://www.chiplot.online/tvbot.html</uri>, accessed on 22 August 2024) [<xref rid="B18-vetsci-12-00132" ref-type="bibr">18</xref>].</p></sec><sec id="sec2dot9-vetsci-12-00132"><title>2.9. Statistical Analysis</title><p>GraphPad Prism 9.0 was used to analyze and visualize the data statistically. Student&#x02019;s <italic toggle="yes">t</italic>-test and Fisher&#x02019;s exact test were used to analyze the data, and <italic toggle="yes">p</italic> values &#x0003c; 0.05 were used to indicate statistical significance.</p></sec></sec><sec sec-type="results" id="sec3-vetsci-12-00132"><title>3. Results</title><sec id="sec3dot1-vetsci-12-00132"><title>3.1. Molecular Subtyping of Clinical and Subclinical Mastitis-Related E. coli Strains</title><p>According to the PCR results of the phylotyped genes (<xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Figure S1</xref>), four phylogroups were found in mastitis-related <italic toggle="yes">E. coli</italic>, including A, B1, C and D (<xref rid="vetsci-12-00132-f002" ref-type="fig">Figure 2</xref>a). B1 (52.9%, 46/87) and A (39.1%, 34/87) were the predominant phylogroups, while a few strains belonging to groups C (4.6%, 4/87) and D (3.4%, 3/87) were found in clinical mastitis strains. The difference analysis showed that there was no significant difference among the four phylogroups between the clinical and subclinical group strains (<italic toggle="yes">p</italic> &#x0003e; 0.05).</p><p>According to the PCR results of the LPS core types, 82 strains were assigned to five different types, while 5 strains could not be assigned to any LPS core type due to the lack of amplification of the PCR assays. R1 was the most prevalent LPS core type of the isolates, accounting for 50.6% (44/87) followed by R3 (19.5%), K12 (9.2%), R4 (9.2%) and R2 (5.7%; <xref rid="vetsci-12-00132-f002" ref-type="fig">Figure 2</xref>b). All the LPS core types were detected in both the subclinical and clinical mastitis-related isolates; there was no significant difference in the distributions of each LPS core type between the two groups (<italic toggle="yes">p</italic> &#x0003e; 0.05).</p><p>After analyzing the seven housekeeping genes, the 87 mastitis-related <italic toggle="yes">E. coli</italic> isolates were assigned to 44 known STs and 2 new STs (ST14828 and ST14829) (<xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Table S3</xref>). According to the phylogenetic tree of the MLST profiles (<xref rid="vetsci-12-00132-f002" ref-type="fig">Figure 2</xref>c), the distribution of mastitis-related <italic toggle="yes">E. coli</italic> strains was highly heterogeneous. The most prevalent ST types were ST10 and ST58, with no significant difference between clinical and subclinical isolates.</p></sec><sec id="sec3dot2-vetsci-12-00132"><title>3.2. Profiles of Virulence Genes</title><p>Among the eighteen detected virulence genes, nine were detected in mastitis-related <italic toggle="yes">E. coli</italic> isolates (<xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Figure S2</xref>). Other than <italic toggle="yes">ompA</italic> and <italic toggle="yes">aer</italic>, which were found in all the isolates, the detection rates of the other eight virulence genes were <italic toggle="yes">traT</italic> (46.0%), <italic toggle="yes">irp2</italic> (14.9%), <italic toggle="yes">iucD</italic> (10.3%), <italic toggle="yes">astA</italic> (10.3%), <italic toggle="yes">hlyA</italic> (8.0%), <italic toggle="yes">cba</italic> (2.3%) and <italic toggle="yes">papC</italic> (1.1%) (<xref rid="vetsci-12-00132-f003" ref-type="fig">Figure 3</xref>a). According to Fisher&#x02019;s exact test, the clinical mastitis isolates tended to possess more virulence genes than the subclinical strains in relation to <italic toggle="yes">traT</italic> (<italic toggle="yes">p</italic> &#x0003c; 0.05), <italic toggle="yes">irp2</italic> (<italic toggle="yes">p</italic> &#x0003c; 0.01) and <italic toggle="yes">iucD</italic> (<italic toggle="yes">p</italic> &#x0003c; 0.001).</p></sec><sec id="sec3dot3-vetsci-12-00132"><title>3.3. Analysis of Biofilm Formation Abilities of Mastitis-Related E. coli</title><p>The <italic toggle="yes">OD</italic><sub>c</sub> value (0.34) was calculated using the arithmetic mean of the negative control (0.237) plus three times the SD (0.036). Most mastitis-related <italic toggle="yes">E. coli</italic> strains (89.7%, 78/87) could form biofilms, and the ratios for strong biofilm formation (SBF), moderate biofilm formation (MBF), weak biofilm formation (WBF) and no biofilm formation (NBF) were 19.5% (17/87), 37.9% (33/87), 32.2% (28/87) and 10.3% (9/87), respectively. Meanwhile, the constructions of biofilm-forming strains in the two groups are shown in <xref rid="vetsci-12-00132-f003" ref-type="fig">Figure 3</xref>b; the subclinical group strains had stronger biofilm formation abilities than the clinical group (<italic toggle="yes">p</italic> &#x0003c; 0.05), which tended to have more strains with no biofilms (19.4%, 7/36) or a weak biofilm (50.0%, 18/36) than the subclinical group, which tended to have more strains with medium (47.1%, 24/51) and strong (29.4%, 15/51) biofilm formation capabilities than the clinical group.</p></sec><sec id="sec3dot4-vetsci-12-00132"><title>3.4. Antimicrobial Susceptibility of Mastitis-Related E. coli</title><p>Mastitis-related <italic toggle="yes">E. coli</italic> exhibited resistance to 11 different antimicrobials except polymyxin B (<xref rid="vetsci-12-00132-t001" ref-type="table">Table 1</xref>). The mastitis-related <italic toggle="yes">E. coli</italic> strains mainly showed severe resistance to four classes of antimicrobials, including tetracyclines (37.9% to tetracycline) &#x003b2;-lactams (36.8% to ampicillin), aminoglycosides (34.5% to streptomycin) and sulfonamides (28.7% to cotrimoxazole); however, they were sensitive to amoxicillin plus clavulanic acid, enrofloxacin, cefepime and ceftazidime, with resistance rates of 1.1%, 4.6%, 5.7% and 6.9%, respectively. The isolates also showed resistance to the other antimicrobials, including gentamycin (17.2%), kanamycin (14.9%) and florfenicol (12.6%). The multiple-drug resistance (MDR&#x02014;resistance to three or more classes of antimicrobials) of mastitis-related <italic toggle="yes">E. coli</italic> was further analyzed as shown in <xref rid="vetsci-12-00132-t002" ref-type="table">Table 2</xref>. The results showed that 36.8% (32/87) of the isolates exhibited multiple-drug resistance. The percentage of isolates resistant to 3, 4, 5 and 6 kinds of drugs was 11.5%, 8.0%, 6.9% and 3.4%, respectively.</p><p>To analyze the differences between clinical and subclinical mastitis, the antimicrobial susceptibilities and the MDR strains of the two groups were analyzed via the chi-square test. Overall, the resistance tendencies of the two groups were similar to most kinds of antimicrobials and MDR distributions, apart from those of ampicillin. There was a significant difference in the drug resistance of ampicillin between subclinical and clinical mastitis isolates; the clinical strains exhibited a higher resistance to ampicillin than the subclinical isolates (<italic toggle="yes">p</italic> &#x0003c; 0.05).</p></sec><sec id="sec3dot5-vetsci-12-00132"><title>3.5. Resistance Genes</title><p>To further investigate the mechanisms of four classes of compounds with serious bacterial resistance, 12 common antibiotic resistance genes were found in the mastitis-related <italic toggle="yes">E. coli</italic> strains (<xref rid="app1-vetsci-12-00132" ref-type="app">Supplementary Figure S3</xref>). Three <italic toggle="yes">&#x003b2;</italic>-lactam resistance genes were found in the isolates. <italic toggle="yes">BlaCTX-M</italic> and <italic toggle="yes">blaTEM</italic> took relatively high percentages, with detection rates of 33.3% (22/87) and 24.1% (15/87), respectively. <italic toggle="yes">BlaOXA</italic> was only detected in two isolates (2.3%). For tetracycline resistance genes, the detection rates of <italic toggle="yes">tetA</italic>, <italic toggle="yes">tetB</italic> and <italic toggle="yes">tetC</italic> were 27.6% (16/87), 18.4% (10/87) and 16.1% (9/87), respectively. For sulfonamide resistance genes, the detection rates of <italic toggle="yes">sul1</italic>, <italic toggle="yes">sul2</italic> and <italic toggle="yes">sul3</italic> were 8.0% (6/87), 18.4% (12/87) and 11.5% (5/87), respectively. For aminoglycoside resistance genes, the detection rates of <italic toggle="yes">aadA</italic>, <italic toggle="yes">strA</italic> and <italic toggle="yes">strB</italic> were 19.5% (12/87), 25.3% (16/87) and 28.7% (17/87), respectively (<xref rid="vetsci-12-00132-f004" ref-type="fig">Figure 4</xref>a).</p><p>The results of the difference analysis of resistance genes showed that there was only a significant difference in the distribution of <italic toggle="yes">blaCTX-M</italic> between the clinical and subclinical isolates (<italic toggle="yes">p</italic> &#x0003c; 0.05). The sequencing results showed that there were seven subtypes of <italic toggle="yes">blaCTX-M</italic> found in mastitis-related <italic toggle="yes">E. coli</italic> isolates, including <italic toggle="yes">blaCTX-M-9</italic>, <italic toggle="yes">blaCTX-M-14</italic>, <italic toggle="yes">blaCTX-M-15</italic>, <italic toggle="yes">blaCTX-M-55</italic>, <italic toggle="yes">blaCTX-M-65</italic>, <italic toggle="yes">blaCTX-M-198</italic> and <italic toggle="yes">blaCTX-M-271</italic>. <italic toggle="yes">blaCTX-M-55</italic> (43.5%, 10/22) was the most prevalent subtype, followed by <italic toggle="yes">blaCTX-M-15</italic> (21.7%, 5/22). Different from <italic toggle="yes">blaCTX-M-55</italic> and <italic toggle="yes">blaCTX-M-15</italic>, <italic toggle="yes">blaCTX-M-9</italic>, <italic toggle="yes">blaCTX-M-14</italic>, <italic toggle="yes">blaCTX-M-65</italic>, <italic toggle="yes">blaCTX-M-198</italic> and <italic toggle="yes">blaCTX-M-271</italic> were only observed in clinical mastitis isolates (<xref rid="vetsci-12-00132-f004" ref-type="fig">Figure 4</xref>b).</p></sec><sec id="sec3dot6-vetsci-12-00132"><title>3.6. Phylogenetic Tree of Mastitis Isolates</title><p>The isolates from different provinces showed high heterogeneity, including mastitis types, STs, LPS core types, biofilms, virulence genes and resistance genes. However, R2 and K12 mastitis-related <italic toggle="yes">E. coli</italic> were closely correlated with ST10, while all the ST58 strains belonged to the R1 type (<xref rid="vetsci-12-00132-f005" ref-type="fig">Figure 5</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-vetsci-12-00132"><title>4. Discussion</title><p>Both bovine clinical and subclinical mastitis caused by <italic toggle="yes">E. coli</italic> are seen at a high frequency in dairy farming. Most previous studies focused on clinical mastitis-related strains. Here, we mainly paid attention to the differences between clinical and subclinical mastitis-related <italic toggle="yes">E. coli</italic> isolates; several differences were found between the two groups, including virulence genes, biofilms and antimicrobial susceptibility.</p><p>Virulence genes play an important role in the pathogenesis of <italic toggle="yes">E. coli</italic>, as the harmless common <italic toggle="yes">E. coli</italic> that inhabit intestines could convert into pathogens when they acquire virulence genes. In this study, most extraintestinal pathogenic <italic toggle="yes">E. coli</italic> (ExPEC) virulence genes were also absent in the detected mastitis-related <italic toggle="yes">E. coli</italic> strains [<xref rid="B19-vetsci-12-00132" ref-type="bibr">19</xref>]. However, frequently reported genes in mastitis-related <italic toggle="yes">E. coli</italic> (<italic toggle="yes">traT</italic>, <italic toggle="yes">irp2</italic> and <italic toggle="yes">iucD</italic>) were more common in clinical mastitis-related <italic toggle="yes">E. coli</italic> isolates than in subclinical mastitis isolates [<xref rid="B20-vetsci-12-00132" ref-type="bibr">20</xref>]. The presence of serum resistance factor, TraT reduced the sensitivity of <italic toggle="yes">E. coli</italic> cells to phagocytosis by macrophages. Generally, <italic toggle="yes">traT</italic> is associated with IncF plasmids [<xref rid="B21-vetsci-12-00132" ref-type="bibr">21</xref>]. The <italic toggle="yes">irp2</italic> gene is linked to the synthesis and regulation of siderophores. Typically, it is part of the high-pathogenicity island, which is located in the chromosomes of pathogenic <italic toggle="yes">E. coli</italic> strains [<xref rid="B22-vetsci-12-00132" ref-type="bibr">22</xref>]. Thus, the mastitis-related <italic toggle="yes">E. coli</italic> strains containing <italic toggle="yes">irp2</italic> should be examined in clinical mastitis as they might cause serious clinical symptoms in the udders of dairy cows. The <italic toggle="yes">iucD</italic> gene encodes an enzyme involved in the biosynthesis of the siderophore aerobactin, which aids in iron acquisition. It is typically found in the ColV plasmid associated with pathogenic strains [<xref rid="B23-vetsci-12-00132" ref-type="bibr">23</xref>]. The presence of these genes might be related to the severity of bovine mastitis, and the immune response caused by subclinical mastitis was usually milder than that of acute mastitis [<xref rid="B24-vetsci-12-00132" ref-type="bibr">24</xref>].</p><p>Biofilms are also considered to be an important pathogenic factor for bacteria, and many mastitis pathogens have been reported to have the ability to form biofilms, including <italic toggle="yes">E. coli</italic> [<xref rid="B25-vetsci-12-00132" ref-type="bibr">25</xref>,<xref rid="B26-vetsci-12-00132" ref-type="bibr">26</xref>]. It helps bacteria to evade the host&#x02019;s innate immune system, increasing resistance to antimicrobial agents. Biofilms are responsible for chronic infection or persistent infection by many pathogenic bacteria. In our study, we observed stronger biofilm formation abilities in subclinical isolates than in clinical strains. It is possible that some subclinical mastitis-related <italic toggle="yes">E. coli</italic> isolates survive in the mammary gland for a lengthy period, inducing persistent infection with the help of strong biofilm formation abilities. Meanwhile, the immune responses in the udders of cows with subclinical mastitis are mild, which is conducive to the persistent infection of subclinical mastitis-related <italic toggle="yes">E. coli</italic> [<xref rid="B27-vetsci-12-00132" ref-type="bibr">27</xref>].</p><p>Antimicrobial resistance (AMR) is a major concern for animal bacterial diseases. In this study, polymyxin B and tetracycline were the most and the least susceptible agents for mastitis-related <italic toggle="yes">E. coli</italic>, respectively, and more than a third of the strains were identified as MDR strains. However, it did not seem to be as serious as other animal-origin <italic toggle="yes">E. coli</italic> isolates [<xref rid="B28-vetsci-12-00132" ref-type="bibr">28</xref>,<xref rid="B29-vetsci-12-00132" ref-type="bibr">29</xref>]. In fact, this might account for the tight restrictions on antibiotic use in mastitis. Broad-spectrum cephalosporins and fluoroquinolones are only recommended for severe clinical symptoms [<xref rid="B30-vetsci-12-00132" ref-type="bibr">30</xref>,<xref rid="B31-vetsci-12-00132" ref-type="bibr">31</xref>]. For antibiotic resistance, the resistance to ampicillin of <italic toggle="yes">E. coli</italic> strains was the only difference between the clinical and subclinical mastitis-related <italic toggle="yes">E. coli</italic> strains. We speculate that this resulted from the induction of the widespread use of penicillin for the treatment of clinical mastitis, while subclinical mastitis lacked timely diagnosis and treatment. The further determination of resistance genes supported our susceptibility results, and it was possible that the distribution of <italic toggle="yes">blaCTX-M</italic> led to the difference between clinical and subclinical mastitis-related <italic toggle="yes">E. coli</italic>.</p><p>Despite a relatively strict medication strategy, quite a few isolates exhibited multiple-drug resistance, and many resistance genes were found in them. Among these multiple-drug resistance strains, extended-spectrum beta-lactamase-producing <italic toggle="yes">E. coli</italic> (ESBL-Ec) are a major concern, as they could be resistant to a broad range of clinically commonly used antibiotics, increasing the risk of treatment failure. This is an urgent global health issue both in human and veterinary medicine. CTX-M-family ESBLs have served as the dominating contributor to the multidrug-resistant profile of <italic toggle="yes">E. coli</italic> over the past decade, and many of them were frequently associated with insertion sequence (IS) ISEcp1, which could transfer horizontally to other bacteria [<xref rid="B9-vetsci-12-00132" ref-type="bibr">9</xref>,<xref rid="B32-vetsci-12-00132" ref-type="bibr">32</xref>]. It was notable that the most popular <italic toggle="yes">blaCTX-M</italic> subtype was <italic toggle="yes">blaCTX-M-55</italic>, which replaced the most prevalent subtype <italic toggle="yes">blaCTX-M-15</italic> in mastitis-related <italic toggle="yes">E. coli</italic> [<xref rid="B33-vetsci-12-00132" ref-type="bibr">33</xref>]. This was identified with the potential risk of the rapid spread of <italic toggle="yes">blaCTX-M-55-positive E. coli</italic> all over the world [<xref rid="B34-vetsci-12-00132" ref-type="bibr">34</xref>]. <italic toggle="yes">BlaOXA</italic> is another important resistance gene in <italic toggle="yes">E. coli</italic> as it is closely related to carbapenem resistance, which is critical for both human and veterinary medicine. Overall, these results remind us of the need to enhance the long-term continuous surveillance of ESBL-positive <italic toggle="yes">E. coli</italic> in bovine mastitis.</p><p>Molecular subtyping is beneficial for tracing back to sources and understanding transmission pathways. In general, the details of the MLST phylogenetic tree of 87 mastitis-related <italic toggle="yes">E. coli</italic> strains showed considerable genetic diversity, and it was hard to distinguish clinical and subclinical mastitis-related <italic toggle="yes">E. coli</italic> as both exhibited high-heterogeneity phylogroups, LPS core types and STs. However, some patterns of resistant genes or virulence genes were observed in the same STs, such as ST23 and ST88. It would be useful to further explore the epidemiological and clinical implications, especially regarding inter-species transmission and the risks associated with resistant strains.</p></sec><sec sec-type="conclusions" id="sec5-vetsci-12-00132"><title>5. Conclusions</title><p>In summary, the present results showed that mastitis-related <italic toggle="yes">E. coli</italic> strains had a high heterogeneity and no significant differences in phylogroups, LPS core types and STs, while virulence genes, biofilm formation, antimicrobial susceptibility and resistance genes were different between the clinical and subclinical group strains. This study aims to provide references for the study of the pathogenic mechanisms of <italic toggle="yes">E. coli</italic> isolates from different types of mastitis.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vetsci-12-00132"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/vetsci12020132/s1">https://www.mdpi.com/article/10.3390/vetsci12020132/s1</uri>, Figure S1: PCR amplification of phylo-typing genes referred to Clermont&#x02019;s PCR methods; Figure S2: PCR amplification of virulence genes existing in mastitis <italic toggle="yes">E. coli</italic> strains; Figure S3: PCR amplification of common antibiotic-resistant genes of mastitis <italic toggle="yes">E. coli</italic> strains; Table S1: specific information of 131 isolates of <italic toggle="yes">E. coli</italic>; Table S2: primers used in this study; Table S3: MLST of mastitis-associated <italic toggle="yes">E. coli</italic> isolates.</p><supplementary-material id="vetsci-12-00132-s001" position="float" content-type="local-data"><media xlink:href="vetsci-12-00132-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>J.M. and X.H. contributed to the study conception and design. Material preparation was performed by J.W., Z.P., Y.Y. (Yong Yu), W.C. and H.Y. Data investigation was performed by J.Z., Z.L., L.L. and H.Z. Data analysis was performed by Z.W. and S.F. The first draft of the manuscript was written by J.Z. and reviewed by W.J., Z.C. and Y.Y. (Yunpeng Yi). All authors commented on previous versions of the manuscript, and all authors read and approved the final manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The animal study protocol was approved by the Ethics Committee of Shanghai Veterinary Research Institution at the Chinese Academy of Agricultural Sciences (CAAS) (Approval Code: CAAS-SHVRI-Po-2019-39; date: 1 September 2019).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all the animal owners involved in this study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The datasets generated during the current study are available from the corresponding author on reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no competing interests.</p></notes><glossary><title>Abbreviations</title><array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CMT</td><td align="left" valign="middle" rowspan="1" colspan="1">California Mastitis Test</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MLST</td><td align="left" valign="middle" rowspan="1" colspan="1">Multilocus sequence typing</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LPS</td><td align="left" valign="middle" rowspan="1" colspan="1">Lipopolysaccharide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ExPEC</td><td align="left" valign="middle" rowspan="1" colspan="1">Extraintestinal pathogenic <italic toggle="yes">E. coli</italic></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AMR</td><td align="left" valign="middle" rowspan="1" colspan="1">Antimicrobial resistance</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MDR</td><td align="left" valign="middle" rowspan="1" colspan="1">Multiple-drug resistance</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ESBL-Ec</td><td align="left" valign="middle" rowspan="1" colspan="1">Extended-spectrum beta-lactamase-producing <italic toggle="yes">E. coli</italic></td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-vetsci-12-00132"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zaatout</surname><given-names>N.</given-names></name>
</person-group><article-title>An overview on mastitis-associated <italic toggle="yes">Escherichia coli</italic>: Pathogenicity, host immunity and the use of alternative therapies</article-title><source>Microbiol. Res.</source><year>2022</year><volume>256</volume><elocation-id>126960</elocation-id><pub-id pub-id-type="doi">10.1016/j.micres.2021.126960</pub-id><pub-id pub-id-type="pmid">35021119</pub-id>
</element-citation></ref><ref id="B2-vetsci-12-00132"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stevens</surname><given-names>M.</given-names></name>
<name><surname>Piepers</surname><given-names>S.</given-names></name>
<name><surname>De Vliegher</surname><given-names>S.</given-names></name>
</person-group><article-title>Mastitis prevention and control practices and mastitis treatment strategies associated with the consumption of (critically important) antimicrobials on dairy herds in Flanders, Belgium</article-title><source>J. Dairy Sci.</source><year>2016</year><volume>99</volume><fpage>2896</fpage><lpage>2903</lpage><pub-id pub-id-type="doi">10.3168/jds.2015-10496</pub-id><pub-id pub-id-type="pmid">26874421</pub-id>
</element-citation></ref><ref id="B3-vetsci-12-00132"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bradley</surname><given-names>A.</given-names></name>
</person-group><article-title>Bovine mastitis: An evolving disease</article-title><source>Vet. J.</source><year>2002</year><volume>164</volume><fpage>116</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1053/tvjl.2002.0724</pub-id><pub-id pub-id-type="pmid">12359466</pub-id>
</element-citation></ref><ref id="B4-vetsci-12-00132"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharun</surname><given-names>K.</given-names></name>
<name><surname>Dhama</surname><given-names>K.</given-names></name>
<name><surname>Tiwari</surname><given-names>R.</given-names></name>
<name><surname>Gugjoo</surname><given-names>M.B.</given-names></name>
<name><surname>Iqbal Yatoo</surname><given-names>M.</given-names></name>
<name><surname>Patel</surname><given-names>S.K.</given-names></name>
<name><surname>Pathak</surname><given-names>M.</given-names></name>
<name><surname>Karthik</surname><given-names>K.</given-names></name>
<name><surname>Khurana</surname><given-names>S.K.</given-names></name>
<name><surname>Singh</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Advances in therapeutic and managemental approaches of bovine mastitis: A comprehensive review</article-title><source>Vet. Q.</source><year>2021</year><volume>41</volume><fpage>107</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1080/01652176.2021.1882713</pub-id><pub-id pub-id-type="pmid">33509059</pub-id>
</element-citation></ref><ref id="B5-vetsci-12-00132"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goetz</surname><given-names>C.</given-names></name>
<name><surname>Tremblay</surname><given-names>Y.D.N.</given-names></name>
<name><surname>Lamarche</surname><given-names>D.</given-names></name>
<name><surname>Blondeau</surname><given-names>A.</given-names></name>
<name><surname>Gaudreau</surname><given-names>A.M.</given-names></name>
<name><surname>Labrie</surname><given-names>J.</given-names></name>
<name><surname>Malouin</surname><given-names>F.</given-names></name>
<name><surname>Jacques</surname><given-names>M.</given-names></name>
</person-group><article-title>Coagulase-negative staphylococci species affect biofilm formation of other coagulase-negative and coagulase-positive staphylococci</article-title><source>J. Dairy Sci.</source><year>2017</year><volume>100</volume><fpage>6454</fpage><lpage>6464</lpage><pub-id pub-id-type="doi">10.3168/jds.2017-12629</pub-id><pub-id pub-id-type="pmid">28624271</pub-id>
</element-citation></ref><ref id="B6-vetsci-12-00132"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ashraf</surname><given-names>A.</given-names></name>
<name><surname>Imran</surname><given-names>M.</given-names></name>
</person-group><article-title>Causes, types, etiological agents, prevalence, diagnosis, treatment, prevention, effects on human health and future aspects of bovine mastitis</article-title><source>Anim. Health Res. Rev.</source><year>2020</year><volume>21</volume><fpage>36</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1017/S1466252319000094</pub-id><pub-id pub-id-type="pmid">32051050</pub-id>
</element-citation></ref><ref id="B7-vetsci-12-00132"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Botrel</surname><given-names>M.A.</given-names></name>
<name><surname>Haenni</surname><given-names>M.</given-names></name>
<name><surname>Morignat</surname><given-names>E.</given-names></name>
<name><surname>Sulpice</surname><given-names>P.</given-names></name>
<name><surname>Madec</surname><given-names>J.Y.</given-names></name>
<name><surname>Calavas</surname><given-names>D.</given-names></name>
</person-group><article-title>Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhone-Alpes, France</article-title><source>Foodborne Pathog. Dis.</source><year>2010</year><volume>7</volume><fpage>479</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1089/fpd.2009.0425</pub-id><pub-id pub-id-type="pmid">19919286</pub-id>
</element-citation></ref><ref id="B8-vetsci-12-00132"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruegg</surname><given-names>P.L.</given-names></name>
</person-group><article-title>A 100-Year Review: Mastitis detection, management, and prevention</article-title><source>J. Dairy Sci.</source><year>2017</year><volume>100</volume><fpage>10381</fpage><lpage>10397</lpage><pub-id pub-id-type="doi">10.3168/jds.2017-13023</pub-id><pub-id pub-id-type="pmid">29153171</pub-id>
</element-citation></ref><ref id="B9-vetsci-12-00132"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nery Garcia</surname><given-names>B.L.</given-names></name>
<name><surname>Dantas</surname><given-names>S.T.A.</given-names></name>
<name><surname>da Silva Barbosa</surname><given-names>K.</given-names></name>
<name><surname>Mendes Mitsunaga</surname><given-names>T.</given-names></name>
<name><surname>Butters</surname><given-names>A.</given-names></name>
<name><surname>Camargo</surname><given-names>C.H.</given-names></name>
<name><surname>Nobrega</surname><given-names>D.B.</given-names></name>
</person-group><article-title>Extended-Spectrum Beta-Lactamase-Producing <italic toggle="yes">Escherichia coli</italic> and Other Antimicrobial-Resistant Gram-Negative Pathogens Isolated from Bovine Mastitis: A One Health Perspective</article-title><source>Antibiotics</source><year>2024</year><volume>13</volume><elocation-id>391</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics13050391</pub-id><pub-id pub-id-type="pmid">38786120</pub-id>
</element-citation></ref><ref id="B10-vetsci-12-00132"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ren</surname><given-names>Q.</given-names></name>
<name><surname>Liao</surname><given-names>G.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Lv</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
</person-group><article-title>Prevalence and characterization of <italic toggle="yes">Staphylococcus aureus</italic> isolates from subclinical bovine mastitis in southern Xinjiang, China</article-title><source>J. Dairy Sci.</source><year>2020</year><volume>103</volume><fpage>3368</fpage><lpage>3380</lpage><pub-id pub-id-type="doi">10.3168/jds.2019-17420</pub-id><pub-id pub-id-type="pmid">32008777</pub-id>
</element-citation></ref><ref id="B11-vetsci-12-00132"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>H.R.</given-names></name>
<name><surname>Jiang</surname><given-names>N.</given-names></name>
</person-group><article-title>Extremely rapid extraction of DNA from bacteria and yeasts</article-title><source>Biotechnol. Lett.</source><year>2006</year><volume>28</volume><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1007/s10529-005-4688-z</pub-id><pub-id pub-id-type="pmid">16369876</pub-id>
</element-citation></ref><ref id="B12-vetsci-12-00132"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clermont</surname><given-names>O.</given-names></name>
<name><surname>Christenson</surname><given-names>J.K.</given-names></name>
<name><surname>Denamur</surname><given-names>E.</given-names></name>
<name><surname>Gordon</surname><given-names>D.M.</given-names></name>
</person-group><article-title>The Clermont <italic toggle="yes">Escherichia coli</italic> phylo-typing method revisited: Improvement of specificity and detection of new phylo-groups</article-title><source>Environ. Microbiol. Rep.</source><year>2013</year><volume>5</volume><fpage>58</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/1758-2229.12019</pub-id><pub-id pub-id-type="pmid">23757131</pub-id>
</element-citation></ref><ref id="B13-vetsci-12-00132"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dissanayake</surname><given-names>D.R.</given-names></name>
<name><surname>Wijewardana</surname><given-names>T.G.</given-names></name>
<name><surname>Gunawardena</surname><given-names>G.A.</given-names></name>
<name><surname>Poxton</surname><given-names>I.R.</given-names></name>
</person-group><article-title>Distribution of lipopolysaccharide core types among avian pathogenic <italic toggle="yes">Escherichia coli</italic> in relation to the major phylogenetic groups</article-title><source>Vet. Microbiol.</source><year>2008</year><volume>132</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2008.05.024</pub-id><pub-id pub-id-type="pmid">18597955</pub-id>
</element-citation></ref><ref id="B14-vetsci-12-00132"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beutin</surname><given-names>L.</given-names></name>
<name><surname>Kaulfuss</surname><given-names>S.</given-names></name>
<name><surname>Herold</surname><given-names>S.</given-names></name>
<name><surname>Oswald</surname><given-names>E.</given-names></name>
<name><surname>Schmidt</surname><given-names>H.</given-names></name>
</person-group><article-title>Genetic analysis of enteropathogenic and enterohemorrhagic <italic toggle="yes">Escherichia coli</italic> serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis</article-title><source>J. Clin. Microbiol.</source><year>2005</year><volume>43</volume><fpage>1552</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1128/JCM.43.4.1552-1563.2005</pub-id><pub-id pub-id-type="pmid">15814965</pub-id>
</element-citation></ref><ref id="B15-vetsci-12-00132"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Wan</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Zuo</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Han</surname><given-names>X.</given-names></name>
<name><surname>Miao</surname><given-names>J.</given-names></name>
</person-group><article-title>The Deletion of yeaJ Gene Facilitates <italic toggle="yes">Escherichia coli</italic> Escape from Immune Recognition</article-title><source>J. Bacteriol.</source><year>2021</year><volume>203</volume><fpage>e0033621</fpage><pub-id pub-id-type="doi">10.1128/JB.00336-21</pub-id><pub-id pub-id-type="pmid">34309400</pub-id>
</element-citation></ref><ref id="B16-vetsci-12-00132"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Z.</given-names></name>
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Li</surname><given-names>B.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Deng</surname><given-names>Y.</given-names></name>
</person-group><article-title>Crystal Violet and XTT Assays on <italic toggle="yes">Staphylococcus aureus</italic> Biofilm Quantification</article-title><source>Curr. Microbiol.</source><year>2016</year><volume>73</volume><fpage>474</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1007/s00284-016-1081-1</pub-id><pub-id pub-id-type="pmid">27324342</pub-id>
</element-citation></ref><ref id="B17-vetsci-12-00132"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Humphries</surname><given-names>R.</given-names></name>
<name><surname>Bobenchik</surname><given-names>A.M.</given-names></name>
<name><surname>Hindler</surname><given-names>J.A.</given-names></name>
<name><surname>Schuetz</surname><given-names>A.N.</given-names></name>
</person-group><article-title>Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition</article-title><source>J. Clin. Microbiol.</source><year>2021</year><volume>59</volume><elocation-id>e0021321</elocation-id><pub-id pub-id-type="doi">10.1128/JCM.00213-21</pub-id><pub-id pub-id-type="pmid">34550809</pub-id>
</element-citation></ref><ref id="B18-vetsci-12-00132"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Cai</surname><given-names>G.</given-names></name>
<name><surname>Cai</surname><given-names>R.</given-names></name>
<name><surname>Hu</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
</person-group><article-title>Tree Visualization By One Table (tvBOT): A web application for visualizing, modifying and annotating phylogenetic trees</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><fpage>W587</fpage><lpage>W592</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad359</pub-id><pub-id pub-id-type="pmid">37144476</pub-id>
</element-citation></ref><ref id="B19-vetsci-12-00132"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fairbrother</surname><given-names>J.H.</given-names></name>
<name><surname>Dufour</surname><given-names>S.</given-names></name>
<name><surname>Fairbrother</surname><given-names>J.M.</given-names></name>
<name><surname>Francoz</surname><given-names>D.</given-names></name>
<name><surname>Nadeau</surname><given-names>E.</given-names></name>
<name><surname>Messier</surname><given-names>S.</given-names></name>
</person-group><article-title>Characterization of persistent and transient <italic toggle="yes">Escherichia coli</italic> isolates recovered from clinical mastitis episodes in dairy cows</article-title><source>Vet. Microbiol.</source><year>2015</year><volume>176</volume><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2014.12.025</pub-id><pub-id pub-id-type="pmid">25631255</pub-id>
</element-citation></ref><ref id="B20-vetsci-12-00132"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guerra</surname><given-names>S.T.</given-names></name>
<name><surname>Orsi</surname><given-names>H.</given-names></name>
<name><surname>Joaquim</surname><given-names>S.F.</given-names></name>
<name><surname>Guimaraes</surname><given-names>F.F.</given-names></name>
<name><surname>Lopes</surname><given-names>B.C.</given-names></name>
<name><surname>Dalanezi</surname><given-names>F.M.</given-names></name>
<name><surname>Leite</surname><given-names>D.S.</given-names></name>
<name><surname>Langoni</surname><given-names>H.</given-names></name>
<name><surname>Pantoja</surname><given-names>J.C.F.</given-names></name>
<name><surname>Rall</surname><given-names>V.L.M.</given-names></name>
<etal/>
</person-group><article-title>Short communication: Investigation of extra-intestinal pathogenic <italic toggle="yes">Escherichia coli</italic> virulence genes, bacterial motility, and multidrug resistance pattern of strains isolated from dairy cows with different severity scores of clinical mastitis</article-title><source>J. Dairy Sci.</source><year>2020</year><volume>103</volume><fpage>3606</fpage><lpage>3614</lpage><pub-id pub-id-type="doi">10.3168/jds.2019-17477</pub-id><pub-id pub-id-type="pmid">32037173</pub-id>
</element-citation></ref><ref id="B21-vetsci-12-00132"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seddon</surname><given-names>C.</given-names></name>
<name><surname>David</surname><given-names>S.</given-names></name>
<name><surname>Wong</surname><given-names>J.L.C.</given-names></name>
<name><surname>Ishimoto</surname><given-names>N.</given-names></name>
<name><surname>He</surname><given-names>S.</given-names></name>
<name><surname>Bradshaw</surname><given-names>J.</given-names></name>
<name><surname>Low</surname><given-names>W.W.</given-names></name>
<name><surname>Frankel</surname><given-names>G.</given-names></name>
<name><surname>Beis</surname><given-names>K.</given-names></name>
</person-group><article-title>Cryo-EM structure and evolutionary history of the conjugation surface exclusion protein TraT</article-title><source>Nat. Commun.</source><year>2025</year><volume>16</volume><fpage>659</fpage><pub-id pub-id-type="doi">10.1038/s41467-025-55834-w</pub-id><pub-id pub-id-type="pmid">39809778</pub-id>
</element-citation></ref><ref id="B22-vetsci-12-00132"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Zhao</surname><given-names>W.</given-names></name>
<name><surname>Shan</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>C.</given-names></name>
<name><surname>Gao</surname><given-names>L.</given-names></name>
<name><surname>Zhao</surname><given-names>R.</given-names></name>
<name><surname>Ao</surname><given-names>P.</given-names></name>
<name><surname>Xiao</surname><given-names>P.</given-names></name>
<name><surname>Lv</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>New insights into the construction of wild-type Saba pig-derived <italic toggle="yes">Escherichia coli irp2</italic> gene deletion strains</article-title><source>3 Biotech</source><year>2021</year><volume>11</volume><elocation-id>408</elocation-id><pub-id pub-id-type="doi">10.1007/s13205-021-02951-0</pub-id><pub-id pub-id-type="pmid">34466347</pub-id>
</element-citation></ref><ref id="B23-vetsci-12-00132"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cummins</surname><given-names>M.L.</given-names></name>
<name><surname>Reid</surname><given-names>C.J.</given-names></name>
<name><surname>Roy Chowdhury</surname><given-names>P.</given-names></name>
<name><surname>Bushell</surname><given-names>R.N.</given-names></name>
<name><surname>Esbert</surname><given-names>N.</given-names></name>
<name><surname>Tivendale</surname><given-names>K.A.</given-names></name>
<name><surname>Noormohammadi</surname><given-names>A.H.</given-names></name>
<name><surname>Islam</surname><given-names>S.</given-names></name>
<name><surname>Marenda</surname><given-names>M.S.</given-names></name>
<name><surname>Browning</surname><given-names>G.F.</given-names></name>
<etal/>
</person-group><article-title>Whole genome sequence analysis of Australian avian pathogenic <italic toggle="yes">Escherichia coli</italic> that carry the class 1 integrase gene</article-title><source>Microb. Genom.</source><year>2019</year><volume>5</volume><fpage>e000250</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000250</pub-id><pub-id pub-id-type="pmid">30672731</pub-id>
</element-citation></ref><ref id="B24-vetsci-12-00132"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goulart</surname><given-names>D.B.</given-names></name>
<name><surname>Mellata</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">Escherichia coli</italic> Mastitis in Dairy Cattle: Etiology, Diagnosis, and Treatment Challenges</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><elocation-id>928346</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.928346</pub-id><pub-id pub-id-type="pmid">35875575</pub-id>
</element-citation></ref><ref id="B25-vetsci-12-00132"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jamal</surname><given-names>M.</given-names></name>
<name><surname>Ahmad</surname><given-names>W.</given-names></name>
<name><surname>Andleeb</surname><given-names>S.</given-names></name>
<name><surname>Jalil</surname><given-names>F.</given-names></name>
<name><surname>Imran</surname><given-names>M.</given-names></name>
<name><surname>Nawaz</surname><given-names>M.A.</given-names></name>
<name><surname>Hussain</surname><given-names>T.</given-names></name>
<name><surname>Ali</surname><given-names>M.</given-names></name>
<name><surname>Rafiq</surname><given-names>M.</given-names></name>
<name><surname>Kamil</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Bacterial biofilm and associated infections</article-title><source>J. Chin. Med. Assoc.</source><year>2018</year><volume>81</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.jcma.2017.07.012</pub-id><pub-id pub-id-type="pmid">29042186</pub-id>
</element-citation></ref><ref id="B26-vetsci-12-00132"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rudenko</surname><given-names>P.</given-names></name>
<name><surname>Sachivkina</surname><given-names>N.</given-names></name>
<name><surname>Vatnikov</surname><given-names>Y.</given-names></name>
<name><surname>Shabunin</surname><given-names>S.</given-names></name>
<name><surname>Engashev</surname><given-names>S.</given-names></name>
<name><surname>Kontsevaya</surname><given-names>S.</given-names></name>
<name><surname>Karamyan</surname><given-names>A.</given-names></name>
<name><surname>Bokov</surname><given-names>D.</given-names></name>
<name><surname>Kuznetsova</surname><given-names>O.</given-names></name>
<name><surname>Vasilieva</surname><given-names>E.</given-names></name>
</person-group><article-title>Role of microorganisms isolated from cows with mastitis in Moscow region in biofilm formation</article-title><source>Vet. World</source><year>2021</year><volume>14</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.14202/vetworld.2021.40-48</pub-id><pub-id pub-id-type="pmid">33642784</pub-id>
</element-citation></ref><ref id="B27-vetsci-12-00132"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dhaouadi</surname><given-names>S.</given-names></name>
<name><surname>Romdhani</surname><given-names>A.</given-names></name>
<name><surname>Bouglita</surname><given-names>W.</given-names></name>
<name><surname>Chedli</surname><given-names>S.</given-names></name>
<name><surname>Chaari</surname><given-names>S.</given-names></name>
<name><surname>Soufi</surname><given-names>L.</given-names></name>
<name><surname>Cherif</surname><given-names>A.</given-names></name>
<name><surname>Mnif</surname><given-names>W.</given-names></name>
<name><surname>Abbassi</surname><given-names>M.S.</given-names></name>
<name><surname>Elandoulsi</surname><given-names>R.B.</given-names></name>
</person-group><article-title>High Biofilm-Forming Ability and Clonal Dissemination among Colistin-Resistant <italic toggle="yes">Escherichia coli</italic> Isolates Recovered from Cows with Mastitis, Diarrheic Calves, and Chickens with Colibacillosis in Tunisia</article-title><source>Life</source><year>2023</year><volume>13</volume><elocation-id>299</elocation-id><pub-id pub-id-type="doi">10.3390/life13020299</pub-id><pub-id pub-id-type="pmid">36836656</pub-id>
</element-citation></ref><ref id="B28-vetsci-12-00132"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roth</surname><given-names>N.</given-names></name>
<name><surname>Kasbohrer</surname><given-names>A.</given-names></name>
<name><surname>Mayrhofer</surname><given-names>S.</given-names></name>
<name><surname>Zitz</surname><given-names>U.</given-names></name>
<name><surname>Hofacre</surname><given-names>C.</given-names></name>
<name><surname>Domig</surname><given-names>K.J.</given-names></name>
</person-group><article-title>The application of antibiotics in broiler production and the resulting antibiotic resistance in <italic toggle="yes">Escherichia coli</italic>: A global overview</article-title><source>Poult. Sci.</source><year>2019</year><volume>98</volume><fpage>1791</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.3382/ps/pey539</pub-id><pub-id pub-id-type="pmid">30544256</pub-id>
</element-citation></ref><ref id="B29-vetsci-12-00132"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aworh</surname><given-names>M.K.</given-names></name>
<name><surname>Kwaga</surname><given-names>J.K.P.</given-names></name>
<name><surname>Hendriksen</surname><given-names>R.S.</given-names></name>
<name><surname>Okolocha</surname><given-names>E.C.</given-names></name>
<name><surname>Thakur</surname><given-names>S.</given-names></name>
</person-group><article-title>Genetic relatedness of multidrug resistant <italic toggle="yes">Escherichia coli</italic> isolated from humans, chickens and poultry environments</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2021</year><volume>10</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s13756-021-00930-x</pub-id><pub-id pub-id-type="pmid">33757589</pub-id>
</element-citation></ref><ref id="B30-vetsci-12-00132"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suojala</surname><given-names>L.</given-names></name>
<name><surname>Kaartinen</surname><given-names>L.</given-names></name>
<name><surname>Pyorala</surname><given-names>S.</given-names></name>
</person-group><article-title>Treatment for bovine <italic toggle="yes">Escherichia coli</italic> mastitis&#x02014;An evidence-based approach</article-title><source>J. Vet. Pharmacol. Ther.</source><year>2013</year><volume>36</volume><fpage>521</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1111/jvp.12057</pub-id><pub-id pub-id-type="pmid">23679229</pub-id>
</element-citation></ref><ref id="B31-vetsci-12-00132"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Poirel</surname><given-names>L.</given-names></name>
<name><surname>Madec</surname><given-names>J.Y.</given-names></name>
<name><surname>Lupo</surname><given-names>A.</given-names></name>
<name><surname>Schink</surname><given-names>A.K.</given-names></name>
<name><surname>Kieffer</surname><given-names>N.</given-names></name>
<name><surname>Nordmann</surname><given-names>P.</given-names></name>
<name><surname>Schwarz</surname><given-names>S.</given-names></name>
</person-group><article-title>Antimicrobial Resistance in <italic toggle="yes">Escherichia coli</italic></article-title><source>Microbiol. Spectr.</source><year>2018</year><volume>6</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1128/microbiolspec.ARBA-0026-2017</pub-id></element-citation></ref><ref id="B32-vetsci-12-00132"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barrios</surname><given-names>H.</given-names></name>
<name><surname>Garza-Ramos</surname><given-names>U.</given-names></name>
<name><surname>Mejia-Miranda</surname><given-names>I.</given-names></name>
<name><surname>Reyna-Flores</surname><given-names>F.</given-names></name>
<name><surname>Sanchez-Perez</surname><given-names>A.</given-names></name>
<name><surname>Mosqueda-Garcia</surname><given-names>D.</given-names></name>
<name><surname>Silva-Sanchez</surname><given-names>J.</given-names></name>
<name><surname>Bacterial Resistance</surname><given-names>C.</given-names></name>
</person-group><article-title>ESBL-producing <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic>: The most prevalent clinical isolates obtained between 2005 and 2012 in Mexico</article-title><source>J. Glob. Antimicrob. Resist.</source><year>2017</year><volume>10</volume><fpage>243</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.jgar.2017.06.008</pub-id><pub-id pub-id-type="pmid">28739224</pub-id>
</element-citation></ref><ref id="B33-vetsci-12-00132"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pehlivanoglu</surname><given-names>F.</given-names></name>
<name><surname>Turutoglu</surname><given-names>H.</given-names></name>
<name><surname>Ozturk</surname><given-names>D.</given-names></name>
</person-group><article-title>CTX-M-15-Type Extended-Spectrum Beta-Lactamase-Producing <italic toggle="yes">Escherichia coli</italic> as Causative Agent of Bovine Mastitis</article-title><source>Foodborne Pathog. Dis.</source><year>2016</year><volume>13</volume><fpage>477</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1089/fpd.2015.2114</pub-id><pub-id pub-id-type="pmid">27182838</pub-id>
</element-citation></ref><ref id="B34-vetsci-12-00132"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>J.T.</given-names></name>
<name><surname>Zhang</surname><given-names>L.J.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>R.M.</given-names></name>
<name><surname>Jiang</surname><given-names>H.X.</given-names></name>
</person-group><article-title>Genomic Insights into Global bla(CTX-M-55)-Positive <italic toggle="yes">Escherichia coli</italic> Epidemiology and Transmission Characteristics</article-title><source>Microbiol. Spectr.</source><year>2023</year><volume>11</volume><elocation-id>e0108923</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.01089-23</pub-id><pub-id pub-id-type="pmid">37358409</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-12-00132-f001"><label>Figure 1</label><caption><p>Bovine mastitis types. (<bold>a</bold>) A dairy cow suffering from clinical mastitis. The diagnosis of clinical mastitis is based on clinical signs, e.g., swelling of the udder, tenderness to touch, fever and depression. (<bold>b</bold>) A dairy cow suffering from subclinical mastitis. Usually, there are no obvious changes in the mammary gland of subclinical mastitis cases, e.g., lack of swelling and other clinical signs. CMT was performed using Lanzhou Mastitis Test (LMT) reagent to verify udder health/quarter milk quality. (<bold>c</bold>) Coagulum negative in the test cup after mixing healthy milk with the LMT reagent; (<bold>d</bold>) there was obvious coagulum formed after mixing the milk sample with the LMT reagent.</p></caption><graphic xlink:href="vetsci-12-00132-g001" position="float"/></fig><fig position="float" id="vetsci-12-00132-f002"><label>Figure 2</label><caption><p>Molecular subtyping of bovine mastitis-related <italic toggle="yes">E. coli.</italic> (<bold>a</bold>) Distribution of five phylogroups in 87 mastitis-related <italic toggle="yes">E coli</italic> strains; (<bold>b</bold>) distribution of LPS core types of mastitis-related <italic toggle="yes">E. coli</italic> strains; (<bold>c</bold>) the eBRUST map of 87 mastitis-related <italic toggle="yes">E. coli</italic> strains according to their STs. STs with red color represent strains from 51 subclinical mastitis-related <italic toggle="yes">E. coli</italic>, and STs with blue color represent strains from 36 clinical mastitis-related <italic toggle="yes">E. coli</italic>.</p></caption><graphic xlink:href="vetsci-12-00132-g002" position="float"/></fig><fig position="float" id="vetsci-12-00132-f003"><label>Figure 3</label><caption><p>Virulence genes and biofilms of 87 mastitis-related <italic toggle="yes">E. coli</italic> strains. (<bold>a</bold>) Distribution of nine different virulence genes in 87 mastitis-related <italic toggle="yes">E coli</italic> strains. (<bold>b</bold>) Pie charts of distribution of strains with strong biofilm formation (SBF), moderate biofilm formation (MBF), weak biofilm formation (WBF) and no biofilm formation (NBF) for subclinical and clinical mastitis-related <italic toggle="yes">E. coli</italic> strains.</p></caption><graphic xlink:href="vetsci-12-00132-g003" position="float"/></fig><fig position="float" id="vetsci-12-00132-f004"><label>Figure 4</label><caption><p>Distribution of resistance genes of mastitis-related <italic toggle="yes">E. coli</italic>. (<bold>a</bold>) Distribution of common drug-resistant genes of four main classes of antibiotic among 87 <italic toggle="yes">E. coli</italic> strains; (<bold>b</bold>) subtypes of <italic toggle="yes">blaCTX-M</italic> genes in mastitis strains.</p></caption><graphic xlink:href="vetsci-12-00132-g004" position="float"/></fig><fig position="float" id="vetsci-12-00132-f005"><label>Figure 5</label><caption><p>Phylogenetic tree of 87 mastitis-related <italic toggle="yes">E. coli</italic> strains according to seven housekeeping genes (<italic toggle="yes">adk</italic>, <italic toggle="yes">fumC</italic>, <italic toggle="yes">gyrB</italic>, <italic toggle="yes">icd</italic>, <italic toggle="yes">mdh</italic>, <italic toggle="yes">purA</italic>, <italic toggle="yes">recA</italic>). The visualization, annotation and decoration of all trees were carried out utilizing tvBOT (<uri xlink:href="https://www.chiplot.online/tvbot.html">https://www.chiplot.online/tvbot.html</uri>, accessed on 22 August 2024). SBF: strain with strong biofilm formation; MBF: strain with moderate biofilm formation; WBF: strain with weak biofilm formation; NBF: strain with no biofilm formation.</p></caption><graphic xlink:href="vetsci-12-00132-g005" position="float"/></fig><table-wrap position="float" id="vetsci-12-00132-t001"><object-id pub-id-type="pii">vetsci-12-00132-t001_Table 1</object-id><label>Table 1</label><caption><p>Antimicrobial susceptibility profiles of <italic toggle="yes">E. coli</italic> isolates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antibiotic Class</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug Agents</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug Breakpoint <break/>(R S I, mm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Susceptible Strains (S)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Intermediate Strains (I)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Resistant Strains (R)</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x003b2;-Lactams</td><td align="center" valign="middle" rowspan="1" colspan="1">
Ampicillin
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;13 14~16 &#x02265;17</td><td align="center" valign="middle" rowspan="1" colspan="1">49.4% (43/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.8% (12/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.8% (32/87)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Amoxicillin/clavulanic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;13 14~17 &#x02265;18</td><td align="center" valign="middle" rowspan="1" colspan="1">96.6% (84/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3% (2/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1% (1/87)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cefepime</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;14 15~17 &#x02265;18</td><td align="center" valign="middle" rowspan="1" colspan="1">89.7% (79/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.6% (4/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.7% (4/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Ceftazidime
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;14 15~17 &#x02265;18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">86.2% (75/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.9% (6/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.9% (6/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sulfonamides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Cotrimoxazole
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;10 11~15 &#x02265;16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69.0% (60/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3% (2/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.7% (25/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetracyclines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Tetracycline
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;14 15~18 &#x02265;19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.4% (36/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20.7% (18/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.9% (33/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phenicols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Florfenicol
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;12 13~17 &#x02265;18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">87.4% (76/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0% (0/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.6% (11/87)</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Aminoglycosides</td><td align="center" valign="middle" rowspan="1" colspan="1">Kanamycin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;13 14~17 &#x02265;18</td><td align="center" valign="middle" rowspan="1" colspan="1">69.0% (60/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">16.1% (14/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">14.9% (13/87)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gentamycin</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;12 13~14 &#x02265;15</td><td align="center" valign="middle" rowspan="1" colspan="1">79.3% (69/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4% (3/87)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.2% (15/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Streptomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;14 15~18 &#x02265;19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.6% (44/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.9% (13/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.5% (30/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluoroquinolones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
Enrofloxacin
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;14 15~20 &#x02265;21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93.1% (81/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3% (2/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.6% (4/87)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polymyxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polymyxin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02264;8 9~11 &#x02265;12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.7% (85/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3% (2/87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1% (0/87)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="vetsci-12-00132-t002"><object-id pub-id-type="pii">vetsci-12-00132-t002_Table 2</object-id><label>Table 2</label><caption><p>Distribution of MDR strains in mastitis-related <italic toggle="yes">E. coli</italic>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classes of Resistant Antibiotics</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Strains of Mastitis-Related <italic toggle="yes">E. coli</italic></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Mastitis-Related <italic toggle="yes">E. coli</italic></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Clinical Strains</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Percentage of Subclinical Strains</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">36.8%</td><td align="center" valign="middle" rowspan="1" colspan="1">36.1%</td><td align="center" valign="middle" rowspan="1" colspan="1">37.3%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">21.8%</td><td align="center" valign="middle" rowspan="1" colspan="1">13.9%</td><td align="center" valign="middle" rowspan="1" colspan="1">27.5%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">11.5%</td><td align="center" valign="middle" rowspan="1" colspan="1">16.7%</td><td align="center" valign="middle" rowspan="1" colspan="1">7.8%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">11.5%</td><td align="center" valign="middle" rowspan="1" colspan="1">13.9%</td><td align="center" valign="middle" rowspan="1" colspan="1">9.8%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">8.0%</td><td align="center" valign="middle" rowspan="1" colspan="1">8.3%</td><td align="center" valign="middle" rowspan="1" colspan="1">7.8%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">6.9%</td><td align="center" valign="middle" rowspan="1" colspan="1">8.3%</td><td align="center" valign="middle" rowspan="1" colspan="1">5.9%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.9%</td></tr></tbody></table></table-wrap></floats-group></article>